Taijun Hana, Akitake Mukasa, Masashi Nomura, Genta Nagae, Shogo Yamamoto, Kenji Tatsuno, Hiroki Ueda, Shiro Fukuda, Takayoshi Umeda, Shota Tanaka, et al. AB019. Detailed analysis of DNA hydroxymethylation observed with the malignant progression of IDH-mutant gliomas. Chinese clinical oncology. 2024. 13. Suppl 1. AB019
Ali M. Nasser, Lisa Melamed, Ethan A. Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa, Logan Muzyka, Hiroaki Wakimoto, Daniel P. Cahill, Julie J. Miller. CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition. Clinical Cancer Research. 2024
Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, Lei Shi, Yi Xiao, Sofiene Dhiab, Qin Xu, Chloe J Slater, Omar I Avila, Joshua Merritt, et al. Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity. Science (New York, N.Y.). 2024. 385. 6705. eadl6173
Adam Sheriff, Hirokazu Takami, Shunsaku Takayanagi, Yosuke Kitagawa, Shota Tanaka, Masako Ikemura, Reiko Matsuura, Yuko Matsushita, Koichi Ichimura, Nobuhito Saito. Embryonal tumor with multilayered rosettes arising from the internal auditory canal of an adult: Illustrative case with molecular investigations. Neuropathology. 2024
Yosuke Kitagawa, Ami Kobayashi, Daniel P Cahill, Hiroaki Wakimoto, Shota Tanaka. Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors. Biochimica et biophysica acta. Reviews on cancer. 2024. 1879. 3. 189102-189102